Incyte Corporation (INCY) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Incyte Corporation (INCY) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

INCY

Market Closed

Incyte Corporation

NASDAQHealthcare Biotechnology

2.62K employees

CEO: William J. Meury

Founded: 1993

$98.22

+$0.00(+NaN%)

Market Cap

19.62B

Beta

0.79

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

92.8%

21.4%

CAGR: 13.9%

Profit after direct costs

Operating Margin

26.1%

1225.6%

CAGR: 23.0%

Core business profitability

Net Margin

25.0%

3845.0%

CAGR: 7.9%

Bottom line profitability

Revenue Growth

21.2%

YoY

CAGR: 14.5%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how INCY allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

92.8%

$4.77B

Operating Margin

26.1%

$1.34B

Net Margin

25.0%

$1.29B

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	2.99B	3.39B	3.70B	4.24B	5.14B	21.2%
Cost of Revenue	(150.99M)	(207.00M)	(254.99M)	(312.10M)	(372.10M)	19.2%
Gross Profit	2.84B	3.19B	3.44B	3.93B	4.77B	21.4%
Operating Expenses
Research & Development	(1.46B)	(1.59B)	(1.63B)	(2.61B)	(2.05B)	-21.4%
Selling, General & Administrative	(739.56M)	(1.00B)	(1.16B)	(1.22B)	(1.38B)	12.6%
General & Administrative	(739.60M)	(1.00B)	(1.16B)	(1.22B)	(1.38B)	12.6%
Depreciation & Amortization	(57.84M)	(67.86M)	(82.66M)	(89.25M)	(93.29M)	4.5%
Operating Income (EBIT)	585.78M	591.63M	655.36M	101.29M	1.34B	1225.6%
Non-Operating Items
Interest Income	—	—	—	128.71M	105.60M	-18.0%
Interest Expense	(1.91M)	(2.67M)	(2.55M)	(2.28M)	(2.43M)	6.5%
Other Income/Expenses (Net)	-15.33M	-62.51M	178.86M	215.34M	321.66M	49.4%
Income Before Tax	570.44M	529.12M	834.22M	316.63M	1.66B	425.7%
Income Tax Expense	(378.14M)	(188.46M)	(236.62M)	(284.01M)	(377.80M)	33.0%
Net Income	948.58M	340.66M	597.60M	32.62M	1.29B	3845.0%
Per Share Metrics
Earnings Per Share (Basic)	$4	$2	$3	$0	$7	4018.8%
Weighted Avg Shares Outstanding	220.43M	222.00M	223.63M	207.11M	195.20M	-5.7%
Weighted Avg Shares Outstanding (Diluted)	222.07M	223.96M	225.93M	210.53M	200.70M	-4.7%
EBITDA	630.20M	599.64M	919.43M	408.16M	1.76B	331.2%

Explore INCY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

INCY in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →